arrow
D

Domenico Alvaro

sapienza university of rome
H指数:94
被引数:5.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Corrigendum to ‘cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ERK1/2 pathway’ (J Hepatol 41 [2004] 528–537)

勘误 'camp通过改变PKA/Src/MEK/ERK1/2通路刺激大鼠肝内胆管上皮的分泌和增殖能力' (J Hepatol 41 [2004] 528-537)

2025-11-070
PRE
Liver disease in people with latent autoimmune diabetes in adults (LADA): A cross-sectional study using magnetic resonance elastography

成人隐匿性自身免疫性糖尿病(LADA)患者的肝病:一项基于磁共振弹性成像的横断面研究

2025-09-080
OAAI
Adherence to United European Gastroenterology Guidelines on Diagnosis and Therapy of Immunoglobulin-G4-Related Digestive Disease

对欧洲胃肠病学联盟关于IgG4相关消化系统疾病诊断和治疗指南的遵循

2025-07-220
OAAI
Retraction: α-1 adrenergic receptor agonists modulate ductal secretion of BDL rats via Ca2+- and PKC-dependent stimulation of cAMP

撤回:α-1肾上腺素能受体激动剂通过Ca2+和PKC依赖性刺激cAMP来调节BDL大鼠的导管分泌

2025-06-190
PRE
Noninvasive Assessment of Portal Hypertension in Patients With Primary Biliary Cholangitis Is Affected by Severity of Cholestasis

非侵入性评估原发性胆汁性胆管病患者的门静脉高压受胆汁淤积严重程度的影响

2024-12-130
OAAI
Clinical management of liver cyst infections: an international, modified Delphi-based clinical decision framework
2024-09-010
PRE
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study
2024-07-060
OAAI
Neutrophil Cathepsin G and Thrombosis in COVID-19
2024-07-050
PRE
Cholestasis impacts on performance of non invasive tests for ruling out high-risk esophageal varices in patients with primary biliary cholangitis and compensated advanced chronic liver disease
2024-02-010
PRE
Longer transplant-free and liver-related event-free survival in obeticholic acid-treated patients with primary biliary cholangitis compared to external controls from two large real-world cohorts
2024-02-011
PRE